Italian CDMO Flamma Group intends to invest $200 million over the next three years to expand its capabilities to meet growing market demand.

Flamma Group, a company specializing in producing and commercializing small molecule APIs for the life science industry, as well as being a CDMO for new chemical entities...

So far, the pharmaceutical industry — including CMOs/CDMOs and CROs — has responded well to the outbreak of the Covid-19 pandemic. However, the coronavirus crisis has...